Patent details

EP4103187 Title: FASUDIL FOR TREATING PSEUDOBULBAR AFFECT

Basic Information

Publication number:
EP4103187
PCT Application Number:
US2021012577
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP217535913
PCT Publication Number:
WO2021162808
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
FASUDIL FOR TREATING PSEUDOBULBAR AFFECT
French Title of Invention:
FASUDIL POUR TRAITER UN AFFECT PSEUDO-BULBAIRE
German Title of Invention:
FASUDIL ZUR BEHANDLUNG DES PSEUDOBULBÄREN AFFEKTS
SPC Number:

Dates

Filing date:
08/01/2021
Grant date:
06/08/2025
EP Publication Date:
21/12/2022
PCT Publication Date:
19/08/2021
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/08/2025
EP B1 Publication Date:
06/08/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
08/01/2041
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
30/07/2025
 
 

Name:
Woolsey Pharmaceuticals, Inc.
Address:
7901 4th Street N, Suite 6987, St. Petersburg, FL 33702, United States (US)

Inventor

1

Name:
MACALLISTER, Thomas
Address:
United States (US)

2

Name:
JACOBSON, Sven
Address:
United States (US)

Priority

1

Priority Number:
202062972440 P
Priority Date:
10/02/2020
Priority Country:
United States (US)

2

Priority Number:
202063007221 P
Priority Date:
08/04/2020
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/551; A61P 25/28; A61K 45/06; A61K 31/506; A61K 31/519; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202532
Publication date:
06/08/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
02/02/2026
Annual Fee Number:
6
Annual Fee Amount:
66 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages